| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/27/2010 | US7763473 applying a liquid to a liquid-receiving surface that a portion of an analysis apparatus, using an absorber material that is stretched into a tensioned line held by a frame, |
| 07/27/2010 | US7763472 reacting a test sample with cysteine and copper iodide, chloride or bromide, under anaerobic conditions in a purge vessel, then analyzing the purge vessel output for nitric oxide and comparing the level of nitric oxide generated with an identical control sample or with a standard sample |
| 07/27/2010 | US7763471 Array of crystallization conditions; accumulating and dispensing reservoirs; aperture for analyzing |
| 07/27/2010 | US7763470 Test element and method of use for analyzing body fluids |
| 07/27/2010 | US7763469 markers, which are miscible in a liquid to be marked and which have characteristic spectral features such as optical absorption spectra or fluorescence (excitation/emission) spectra for distinguishing them from the marked liquid without the need to extract the markers from the marked liquid |
| 07/27/2010 | US7763468 analyzing a sample by utilizing a double integration circuit for outputting a physical quantity related to the output from an analytical tool |
| 07/27/2010 | US7763443 Expression vector comprising nucleotide sequences coding green fluorescent protein for use as reporter molecule in gene expression analysis |
| 07/27/2010 | US7763441 Modulators of gluconeogenesis |
| 07/27/2010 | US7763440 Diagnosis of pre-eclampsia |
| 07/27/2010 | US7763439 Two-photon absorbing dipyrrometheneboron difluoride dyes and their applications |
| 07/27/2010 | US7763438 Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan |
| 07/27/2010 | US7763437 Methods for identifying compounds that regulate β-Arrestin signaling complexes |
| 07/27/2010 | US7763436 comparing the levels of autoantibodies to mannose binding lectin (MBL) in the human subject suspected to be having rheumatoid arthritis to the level of autoantibodies to MBL in the blood of normal control individuals, as determined by enzyme-linked immunosorbent assay (ELISA) |
| 07/27/2010 | US7763435 Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity |
| 07/27/2010 | US7763434 monoclonal antibodies against interleukin-15(IL-15) that prevent IL-15 from effecting signal transduction through the beta - or gamma -subunits of the IL-15 receptor complex; treating transplant rejection and graft-versus-host disease |
| 07/27/2010 | US7763433 Analyte detection system |
| 07/27/2010 | US7763432 monoclonal or monoclonal antibodies that binds specifically to pregnancy associated antigens, used in immunoassays for detecting pregnancy-associated glycoproteins, that are structurally related to the pepsins |
| 07/27/2010 | US7763431 screening for modulators and can be used as flavor additives in compositions for human or animal consumption |
| 07/27/2010 | US7763430 Diagnostic assay for anti-von Willebrand Factor cleaving protease (ADAMTS13) antibodies |
| 07/27/2010 | US7763429 Compound containing farnesyl diphosphate for modulating TRPV3 function and use thereof |
| 07/27/2010 | US7763422 evaluating the amount of cancer cells existing in pancreatic cells or tissues, by measuring the methylation frequency of Fibrillin2 gene or an index value having the correlation therewith, and comparing with a control; medical diagnosis |
| 07/27/2010 | US7763419 harvesting skin tissue from an animal, then identifying marker analyte selected from melanocyte stimulating hormone, microtubules composed of tubulin and associated proteins, and tyrosinases, and evaluating the effect of said test product on the tissue |
| 07/27/2010 | US7763418 using an antibodies specific for one or more activated Rho guanosine triphospahtase peptides such as Rho-associated, coiled-coil containing protein kinase (ROCK1) |
| 07/27/2010 | US7763283 Nitric oxide (NO) releasing material |
| 07/27/2010 | US7763282 Quaternary compounds comprising propolis as the active substance |
| 07/27/2010 | US7763262 Attenuated yiaO mutants of Pasteurellaceae bacteria |
| 07/27/2010 | US7763252 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |
| 07/27/2010 | US7763249 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |
| 07/27/2010 | US7763246 Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor |
| 07/27/2010 | US7763210 Compliant microfluidic sample processing disks |
| 07/27/2010 | US7763208 System and method for sensing and analyzing gases |
| 07/27/2010 | US7763207 Throughflow device for measuring platelet function of primary hemostasis, aggregation and/or coagulation and/or viscosity of blood |
| 07/27/2010 | US7763175 Electromagnetic probe device |
| 07/27/2010 | US7763154 Method and sensor element for determining a gas in a gas mixture |
| 07/27/2010 | US7762143 Penetration-type pipe strain gauge |
| 07/27/2010 | US7762131 System for predicting changes in a drilling event during wellbore drilling prior to the occurrence of the event |
| 07/27/2010 | US7762127 Method for determining the composition of a fuel mixture |
| 07/27/2010 | US7762123 Seal for measuring device |
| 07/27/2010 | US7762121 Method and apparatus for sensing hydrogen gas |
| 07/27/2010 | CA2521370C Biosensor system |
| 07/27/2010 | CA2514160C Device and method for determining and/or monitoring a process variable of a medium |
| 07/27/2010 | CA2466172C Biocatalytic solgel microarrays |
| 07/27/2010 | CA2462686C Fret protease assays for clostridial toxins |
| 07/27/2010 | CA2441191C Solid electrolyte sensor for monitoring the concentration of an element in a fluid particularly molten metal |
| 07/27/2010 | CA2424637C Selective binding materials |
| 07/27/2010 | CA2422440C Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in situ analysis |
| 07/27/2010 | CA2420717C Artificial intelligence system for genetic analysis |
| 07/27/2010 | CA2413475C Zap-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll) |
| 07/27/2010 | CA2404000C A functional assay of high-density lipoprotein |
| 07/27/2010 | CA2392080C Blood-compatible polymer surfaces |
| 07/27/2010 | CA2375820C The myostatin gene promoter and inhibition of activation thereof |
| 07/27/2010 | CA2375027C High specificity primers, amplification methods and kits |
| 07/27/2010 | CA2338989C Antibodies for detecting microorganisms |
| 07/27/2010 | CA2323091C Nephrin gene and protein |
| 07/27/2010 | CA2318880C Determination of a genotype of an amplification product at multiple allelic sites |
| 07/27/2010 | CA2287872C Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/27/2010 | CA2263152C Immunologically active proteins from borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines |
| 07/27/2010 | CA2237717C Screening assay for compounds stimulating somatostatin and insulin production |
| 07/27/2010 | CA2224080C Relaxin-like factor and methods and uses thereof |
| 07/27/2010 | CA2195385C An artificial recombinant substrate (ragg 1) and native aggrecan to study the proteolytic activity of 'aggrecanase' in cell culture systems |
| 07/23/2010 | CA2650750A1 Method and system for determining particle size distribution and filterable solids in a bitumen-containing fluid |
| 07/22/2010 | WO2010083532A1 Fatty acid binding proteins as drug targets for modulation of endocannabinoids |
| 07/22/2010 | WO2010083484A2 System and method for characterization of oral, systemic and mucosal tissue utilizing raman spectroscopy |
| 07/22/2010 | WO2010083471A1 Luminescent compounds |
| 07/22/2010 | WO2010083470A1 Methods of determining patient response by measurement of her-3 |
| 07/22/2010 | WO2010083463A1 Methods of determining patient response by measurement of her-2 expression |
| 07/22/2010 | WO2010083392A2 Ets-2 biomarkers for fibrotic diseases and uses thereof |
| 07/22/2010 | WO2010083327A2 Measuring levels of frataxin |
| 07/22/2010 | WO2010083289A1 Detection devices and methods |
| 07/22/2010 | WO2010083253A2 Cd47 related compositions and methods for treating immunological diseases and disorders |
| 07/22/2010 | WO2010083252A2 Ratio based biomarkers and methods of use thereof |
| 07/22/2010 | WO2010083204A2 Noninvasive measurement of flavonoid compounds in biological tissue |
| 07/22/2010 | WO2010083046A2 Methods for using next generation sequencing to identify 5-methyl cytosines in the genome |
| 07/22/2010 | WO2010083044A1 Diagnosis and treatment of autism spectrum disorders |
| 07/22/2010 | WO2010082860A1 Method and device for nanopore based single-molecule protein/ protein interaction detection |
| 07/22/2010 | WO2010082845A1 Honey analysis |
| 07/22/2010 | WO2010082790A2 Electroresponsive device for extending the life of biosensors, and a biosensor employing the same |
| 07/22/2010 | WO2010082743A2 Method for checking and quantifying protein-ligand interaction by combining a crosslinking method and accelerator mass spectroscopy |
| 07/22/2010 | WO2010082681A1 Immuno-latex particles and process for producing same |
| 07/22/2010 | WO2010082497A1 Method for measuring systemic concentration of protein-containing medicament |
| 07/22/2010 | WO2010082385A1 Mouse having human hepatocytes transplanted therein |
| 07/22/2010 | WO2010082133A2 Modulator assay |
| 07/22/2010 | WO2010082034A1 Antibody |
| 07/22/2010 | WO2010082009A1 Screening assay |
| 07/22/2010 | WO2010081981A2 Method for determining the concentration of a plurality of compounds in a drilling fluid |
| 07/22/2010 | WO2010081876A1 A measuring unit for measuring characteristics of a sample liquid, in particular viscoelastic characteristics of a blood sample |
| 07/22/2010 | WO2010081875A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 07/22/2010 | WO2010081848A1 System and method for analyzing a body fluid |
| 07/22/2010 | WO2010081784A1 Assembly of absolutely quantified peptide and phosphopeptide solutions via element mass spectrometry |
| 07/22/2010 | WO2010081778A1 Blockers of parp for the prevention and treatment of helicobacter pylori induced gastric cancer |
| 07/22/2010 | WO2010081729A1 Method for the assessment of severity of liver cirrhosis |
| 07/22/2010 | WO2010081727A2 Means and methods for differentiating between fibrosis and cirrhosis |
| 07/22/2010 | WO2010081585A1 Measuring device, arrangement, and method for measuring a content of at least one component in a fluid fuel |
| 07/22/2010 | WO2010081529A1 Folded carrier tape having consumable elements |
| 07/22/2010 | WO2010081240A1 Diagnostic assays for prostate cancer using psp94 and psa biomarkers |
| 07/22/2010 | WO2010081219A1 A handheld diagnostic test device and method for use with an electronic device and a test cartridge in a rapid diagnostic test |
| 07/22/2010 | WO2010065568A3 METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95 |
| 07/22/2010 | WO2010061283A3 Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis |
| 07/22/2010 | WO2010052307A3 Test element for detecting an analyte in a sample |
| 07/22/2010 | WO2010048627A3 Potentiometric sensors based on surface molecular imprinting, and nanoparticle composition for the detection of cancer biomarkers and viruses and methods of use thereof |